Developing a national Real-World Evidence decision making framework

制定国家真实世界证据决策框架

• 批准号: 411907
• 负责人: Chan Kelvin K
• 金额: $ 0.73万
• 依托单位: Sunnybrook Research Institute (Toronto, Ontario)
• 依托单位国家: 加拿大
• 项目类别: Miscellaneous Programs
• 财政年份: 2019
• 资助国家: 加拿大
• 起止时间: 2019-09-01 至 2020-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=411907&lang=en
• 关键词: Cancer; Decusion Making; Drug Funding; Health Services Research; Health Technology Assessment; Healthcare Policy; Real-World Evidence; Stakeholder Engagement

Background: The Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) collaboration is a pan-Canadian team of researchers, clinicians, decision-makers, and others committed to establishing a framework for the use of real-world evidence (RWE)

背景：加拿大抗癌药物价值的真实世界证据（CanREValue）合作是一个由研究人员、临床医生、决策者和其他致力于建立真实世界证据使用框架（RWE）的泛加拿大团队。